BLEOMYCIN

Generic: BLEOMYCIN SULFATE

Fresenius Kabi USAManufacturer
INTRAMUSCULAR, INTRAPLEURAL, INTRAVENOUS, SUBCUTANEOUSRoute
BLEOMYCIN SULFATEActive Substance
2008-01-28Original Approval

BLEOMYCIN is FDA application ANDA065185, sponsored by FRESENIUS KABI USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
FEBRILE NEUTROPENIA
828 reports
2
OFF LABEL USE
803 reports
3
NEUTROPENIA
605 reports
4
DRUG INEFFECTIVE
510 reports
5
PYREXIA
467 reports
6
PULMONARY TOXICITY
417 reports
7
VOMITING
379 reports
8
NAUSEA
370 reports
9
ANAEMIA
360 reports
10
THROMBOCYTOPENIA
356 reports